MediciNova Highlights Strategic Focus On Non-Dilutive Funding With NIH-Funded ALS Trial And Canadian Long COVID Study, Reports Strong $42.3M Cash Position, And Reaffirms Commitment To Sustainable Growth And Shareholder Transparency

BenzingaNov 19 09:17 ET

MediciNova Provides Update in Letter to Stockholders

TipRanksNov 19 09:15 ET

Express News | Medicinova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

ReutersNov 19 09:00 ET

MediciNova Granted Notice of Allowance for MN-001 Patent by USPTO

TipRanksNov 14 18:05 ET

Express News | MediciNova Receives Notice Of Allowance From US PTO For A Pending Patent Application For MN-001 (Tipelukast) To Cover 'Method To Decrease Triglyceride Synthesis In A Liver Of A Subject'

BenzingaNov 14 18:01 ET

Express News | MediciNova Inc - Patent Is Expected to Expire No Earlier Than May 26, 2042

ReutersNov 14 18:00 ET